Title |
Neuroprotection for treatment of glaucoma in adults
|
---|---|
Published by |
John Wiley & Sons, Ltd, February 2013
|
DOI | 10.1002/14651858.cd006539.pub3 |
Pubmed ID | |
Authors |
Sena, Dayse F, Lindsley, Kristina |
Abstract |
Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commonest form of glaucoma, is a chronic condition that may or may not present with increased intraocular pressure (IOP). Neuroprotection for glaucoma refers to any intervention intended to prevent optic nerve damage or cell death. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
United Kingdom | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 108 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 23 | 21% |
Other | 15 | 14% |
Student > Ph. D. Student | 15 | 14% |
Student > Master | 14 | 13% |
Student > Doctoral Student | 11 | 10% |
Other | 26 | 24% |
Unknown | 6 | 5% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 57 | 52% |
Agricultural and Biological Sciences | 12 | 11% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Nursing and Health Professions | 4 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 16 | 15% |
Unknown | 11 | 10% |